1. Home
  2. XIN vs NKGN Comparison

XIN vs NKGN Comparison

Compare XIN & NKGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XIN
  • NKGN
  • Stock Information
  • Founded
  • XIN 1997
  • NKGN 2017
  • Country
  • XIN China
  • NKGN United States
  • Employees
  • XIN N/A
  • NKGN 63
  • Industry
  • XIN Homebuilding
  • NKGN Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • XIN Consumer Discretionary
  • NKGN Health Care
  • Exchange
  • XIN Nasdaq
  • NKGN Nasdaq
  • Market Cap
  • XIN 15.7M
  • NKGN 8.1M
  • IPO Year
  • XIN N/A
  • NKGN N/A
  • Fundamental
  • Price
  • XIN $3.80
  • NKGN $0.23
  • Analyst Decision
  • XIN
  • NKGN
  • Analyst Count
  • XIN 0
  • NKGN 0
  • Target Price
  • XIN N/A
  • NKGN N/A
  • AVG Volume (30 Days)
  • XIN 367.4K
  • NKGN 311.9K
  • Earning Date
  • XIN 01-01-0001
  • NKGN 11-12-2024
  • Dividend Yield
  • XIN N/A
  • NKGN N/A
  • EPS Growth
  • XIN N/A
  • NKGN N/A
  • EPS
  • XIN N/A
  • NKGN N/A
  • Revenue
  • XIN $667,143,185.00
  • NKGN N/A
  • Revenue This Year
  • XIN N/A
  • NKGN N/A
  • Revenue Next Year
  • XIN N/A
  • NKGN N/A
  • P/E Ratio
  • XIN $0.48
  • NKGN N/A
  • Revenue Growth
  • XIN N/A
  • NKGN N/A
  • 52 Week Low
  • XIN $1.92
  • NKGN $0.20
  • 52 Week High
  • XIN $7.05
  • NKGN $5.10
  • Technical
  • Relative Strength Index (RSI)
  • XIN 49.56
  • NKGN 20.35
  • Support Level
  • XIN $3.61
  • NKGN $0.36
  • Resistance Level
  • XIN $4.50
  • NKGN $0.30
  • Average True Range (ATR)
  • XIN 0.75
  • NKGN 0.04
  • MACD
  • XIN -0.09
  • NKGN 0.00
  • Stochastic Oscillator
  • XIN 6.07
  • NKGN 9.44

About XIN Xinyuan Real Estate Co Ltd

Xinyuan Real Estate Co Ltd operates as a real estate developer and property manager in China. It focuses on developing residential projects, which typically consist of multiple residential buildings that include multi-layer apartment buildings, and others. Its several projects include auxiliary services and amenities such as retail outlets, leisure and health facilities, kindergartens, and schools. It aims to provide comfortable and convenient real estate-related products and services to middle-class consumers.

About NKGN NKGen Biotech Inc.

NKGen Biotech Inc is a biotechnology company developing cell therapies for neurodegenerative and oncological diseases based on activated NK cells. NK cells are part of the human innate immune response system that can selectively identify and destroy abnormal or diseased cells. Its product candidates are based on a proprietary manufacturing and cryopreservation process that produces SuperNKTM (SNK) cells that have shown increased activity as compared to the starting population of NK cells, based on the results of in vitro experiments performed by NKMAX, as defined by parameters such as cytotoxicity, cytokine production and activating receptor expression. SNK cells can be produced in large quantities and cryopreserved while maintaining high levels of cytotoxicity.

Share on Social Networks: